Work

TET1 is a tumor suppressor of hematopoietic malignancy

Year: 2015

Type: article

Source: Nature Immunology

DOI: 10.1038/ni.3148

Authors: Luisa Cimmino, Meelad M Dawlaty, Delphine Ndiaye-Lobry, Yoon Sing Yap, Sofia Bakogianni, Yiting Yu, Sanchari Bhattacharyya, Rita Shaknovich, Huimin Geng, Camille Lobry, Jasper Mullenders, Bryan King, Thomas Trimarchi, Beatriz Aranda-Orgilles, Cynthia Liu, Steven Shen, Amit K Verma, Rudolf Jaenisch, Iannis Aifantis

Institutions: Howard Hughes Medical Institute, NYU Langone Health, New York University, Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Albert Einstein College of Medicine, Montefiore Medical Center, Cornell University, Weill Cornell Medicine, University of California, San Francisco

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Howard Hughes Medical Institute, National Institutes of Health, National Cancer Institute, National Center for Advancing Translational Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G1582611089, G1734361364, G1789144376, University of Minnesota Clinical and Translational Science Institute (UMN CTSI), G2570684827, G2791860145, G2917633669, In Vitro Reprogramming of Somatic Cells into Pluripotent ES-like Cells, G4118738396, G4401428767, G4871940255, G5476451311, G6644033288, G6912321542, G7088928756, G7540779122, G8437647162, Cancer Center Support Grant, G952953977

OpenAlex ID: W2011843149

FWCI: 11.97

Cites: 59

Cited by: 229

Related to: 10